Ping An Biomedical Swaps Auditor WWC for Edston Global PAC
PASW sits 18% above its 52-week low of $0.11 on light trading volume (0.1× avg).
Summary
Ping An Biomedical dismissed its auditor WWC, P.C. and engaged Edston Global PAC, effective August 5–6, 2026. No disagreements were reported, but the change adds governance uncertainty for a company already facing Nasdaq delisting risk.
Key Events · Corporate Governance and Compliance · PASW
-
Auditor Dismissal
The board resolved not to reappoint WWC, P.C. as independent auditor, effective August 5, 2026. WWC had audited the company since fiscal year 2020.
-
New Auditor Appointed
Edston Global PAC, a Singapore-based firm, was engaged as the new independent auditor effective August 6, 2026. There were no prior consultations with Edston on accounting or auditing matters.
-
No Disagreements Reported
The company states there were no adverse opinions, disagreements, or reportable events with WWC during its tenure. WWC's letter agrees with the company's statements.
-
Governance Risk
An auditor change at a micro-cap company under Nasdaq delisting pressure raises oversight concerns. The new auditor's ability to handle Hong Kong-based operations is untested.
Analysis · PASW · Manufacturing
Effective August 5–6, 2026, Ping An Biomedical dismissed its long-time auditor WWC, P.C. and brought on Edston Global PAC. Both the company and the outgoing auditor confirm there were no disagreements or reportable events during WWC's tenure. Although the filing characterizes the move as a routine non-reappointment, auditor changes at micro-cap companies often raise governance flags—especially when the company is under Nasdaq delisting pressure. The new auditor is a small Singapore-based firm, which may face challenges auditing a Hong Kong-based company. This change arrives just months after the company secured a Nasdaq minimum bid price extension and amid a series of strategic moves, adding uncertainty to the company's financial oversight.
At the time of this filing, PASW was trading at $0.13 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $3.2M. The 52-week trading range was $0.11 to $1.22. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.